GO
Loading...

Cramer’s One-on-One With Regeneron CEO

On Tuesday, Cramer spoke with Dr. Leonard Schleifer, president and CEO of Regeneron Pharmaceuticals .

Based in Tarrytown, N.Y., Regeneron is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for the treatment of serious medical conditions, including and especially in the area of eye care.

Cramer has long been behind the company’s stock. He first recommended REGN when it was trading at around $5 a share in spring 2005. Those who bought the stock at those levels and have held on have seen a 1,425 percent gain. But does this stock have even more room to run? Find out by watching video of Cramer’s full conversation with Dr. Leonard Schleifer.









Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
REGN
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.

Cramer's New Book